RenovoRx said yesterday that it won label expansion for the RenovoCath dual-balloon infusion catheter to include the delivery of chemotherapeutics. The device isolates segments of the peripheral vasculature, allowing doctors to deliver therapeutics in a more targeted fashion, according to the Los Altos, Calif.-based company.
“This additional FDA indication marks yet another milestone for RenovoRx as we continue to work towards making our technology available to physicians to treat difficult diseases,” CEO Shaun Bagai said in prepared remarks.
Get the full story at our sister site, Drug Delivery Business News.
The post RenovoRx wins label expansion for RenovoCath device appeared first on MassDevice.
from MassDevice http://ift.tt/2nDUPHu
Cap comentari:
Publica un comentari a l'entrada